Rest EZ, Inc. reported no revenue for the three months ended June 30, 2025, maintaining the same level as the previous year. The company’s financial statements indicate a net loss of $0 for the current quarter, compared to a net loss of $33 for the same period in 2024. General and administrative expenses decreased to $0 from $33 year-over-year, reflecting a significant reduction in operational costs. The company’s total assets and stockholders' equity remained unchanged at $300, while the accumulated deficit stood at $286,101 as of June 30, 2025.
In terms of operational developments, Rest EZ, Inc. has transitioned to full production and distribution of its sole product, the Rest EZ Sleep Aid Supplement, a liquid gel capsule. The company has not yet distributed this product to any customers, despite having sold 33,235 bottles for a total of $284,443 in sales prior to the current quarter. The company’s inventory remains at zero, indicating that no new products have been manufactured or sold during this reporting period. The company continues to market its product through various channels, including wholesalers, retailers, and its website.
The company’s employee headcount remains at one, with Brandon Sosa serving as the sole executive officer and director. The company has not made any significant acquisitions or organizational changes during this quarter. The lack of revenue generation raises concerns about the company’s ability to sustain operations without additional capital. The financial statements highlight a substantial doubt about the company’s ability to continue as a going concern, emphasizing the need for future investment opportunities and financing.
Looking ahead, Rest EZ, Inc. acknowledges the challenges it faces in generating sufficient cash flow to support its operations. The company’s ability to raise capital is critical for its survival, as it has not yet established a consistent revenue stream. Management has indicated that the continuation of the company is dependent on its ability to secure financing and generate profits from future operations. The company has not provided specific forward-looking statements regarding its financial outlook, but it recognizes the risks associated with competition and market conditions in the dietary supplement industry.
About REST EZ Inc.
Rest EZ, Inc. develops and markets sleep aid soft gel capsules containing natural ingredients like melatonin and amino acids. The company distributes its products through wholesalers, retail stores, and online channels, targeting adults with sleep difficulties. It relies on outsourced manufacturing, emphasizes product quality, and aims to build brand recognition through direct sales and marketing efforts in a competitive dietary supplement industry.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.